STX1A

Chr 7

syntaxin 1A

Also known as: HPC-1, P35-1, STX1, SYN1A

This gene encodes a member of the syntaxin superfamily. Syntaxins are nervous system-specific proteins implicated in the docking of synaptic vesicles with the presynaptic plasma membrane. Syntaxins possess a single C-terminal transmembrane domain, a SNARE [Soluble NSF (N-ethylmaleimide-sensitive fusion protein)-Attachment protein REceptor] domain (known as H3), and an N-terminal regulatory domain (Habc). Syntaxins bind synaptotagmin in a calcium-dependent fashion and interact with voltage dependent calcium and potassium channels via the C-terminal H3 domain. This gene product is a key molecule in ion channel regulation and synaptic exocytosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]

OMIMResearchGenerating clinical summary…
MultiplemechanismLOEUF 0.29
Clinical SummarySTX1A
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.98). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
6 unique Pathogenic / Likely Pathogenic· 25 VUS of 55 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.29LOEUF
pLI 0.979
Z-score 3.50
OE 0.06 (0.020.29)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
2.40Z-score
OE missense 0.51 (0.430.61)
98 obs / 191.4 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.06 (0.020.29)
00.351.4
Missense OE?0.51 (0.430.61)
00.61.4
Synonymous OE?0.86
01.21.6
LoF obs/exp: 1 / 16.2Missense obs/exp: 98 / 191.4Syn Z: 0.95
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedSTX1A-related neurodevelopmental disorder without epilepsyOTHERAR
moderateSTX1A-related neurodevelopmental disorder with epilepsyOTHERAD

This gene — mechanism propensity

DN
0.6648th %ile
GOF
0.6052th %ile
LOF
0.4825th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). The Badonyi & Marsh model scores dominant-negative highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF33% of P/LP variants are LoF · LOEUF 0.29
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

55 submitted variants in ClinVar

Classification Summary

Pathogenic1
Likely Pathogenic5
VUS25
Likely Benign15
Benign1
1
Pathogenic
5
Likely Pathogenic
25
VUS
15
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
0
0
0
1
Likely Pathogenic
1
4
0
0
5
VUS
1
24
0
0
25
Likely Benign
0
6
3
6
15
Benign
0
0
0
1
1
Total3343747

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

164 pathogenic / likely-pathogenic (of 170) ClinVar copy-number / structural variants overlap STX1A — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

STX1A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.